Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndrome

Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndrome - Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044082

Enrollment

100

Registered

2021-05-01

Start date

2021-05-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POEMS syndrome

Interventions

Blood test: Cytokine and neurofilament light chain assay Blood test: Cytokine and neurofilament light chain assay

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patents with POEMS syndrome 1. 20 years-old or older at the time of obtaining consent 2. Patients with POEMS syndrome who visited Chiba University Hospital after 2000 Healthy volunteers 1. 20 years-old or older at the time of obtaining consent 2. Individuals who have no complications

Exclusion criteria

Exclusion criteria: Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study

Design outcomes

Primary

Measure	Time frame
Cytokine Neurofilament light chain Clinical symptoms	—

Countries

Japan

Contacts

Public ContactTomoki Suichi

Graduate School of Medicine, Chiba University Neurology

t-suichi@plum.ocn.ne.jp+81432227171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026